A bladder preserving protocol comprising combined external-beam radiotherapy and interstitial brachytherapy for the treatment of bladder cancer has been reported as a viable alternative to cystectomy.

This transcript has been edited for clarity. Cheryl Lee, MD: Welcome to Medscape InDiscussion. I'm Cheryl Lee, and today we'll be discussing a topic that has continued to be controversial. I'm ...

Johnson & Johnson (NYSE:JNJ) announced today that new data from the investigational Cohort 4 of the Phase 2b SunRISe-1 study show treatment with gemcitabine intravesical system resulted in high ...

"We found CKD to be independently associated with a higher likelihood of nonorgan confined disease and lymph node metastases as well as postoperative transfusion and 90-day readmissions." – Nguyen, et ...

A retrospective study showed that recurrence of bladder cancer after radical cystectomy can occur up to 4 years after surgery. Patients who have no residual disease following radical cystectomy for ...

PATIENTS AND METHODS: All patients undergoing radical cystectomy with bilateral pelvic iliac lymphadenectomy, with the intent to cure, for transitional-cell carcinoma of the bladder between July 1971 ...

Bladder removal (radical cystectomy) is an effective treatment option for muscle-invasive bladder cancer but still a major operation. MSK is taking a leading role in helping more people with bladder ...

Robot-assisted radical cystectomy with intracorporeal urinary diversion vs open radical cystectomy resulted in a median of 82 vs 80 days alive and out of the hospital within 90 days of surgery. While ...

Prophylactic tranexamic acid showed no reduction in blood transfusion rates in open radical cystectomy patients. The trial found no significant differences in secondary outcomes, including estimated ...

New data show that a large subset of patients with muscle-invasive bladder cancer (MIBC) can avoid cystectomy and enjoy long-term, bladder-intact, disease-free survival. Among 64 study participants ...